Speaker illustration

Doctor Etienne GUILLOT

Sanofi R&D, Chilly-Mazarin (France)

Peptidomimetic targeting of CavBeta2 improves contractility in models of senescence- or genetically (MYBPC3 KI)- induced heart failure

Event: ESC Congress 2019

Topic: Heart Failure

Session: Heart failure: from bench to bed


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb